DXCM Q3 2021 Earnings — DexCom, Inc. Revenue & Financial Results | Market Cap Arena

DXCMDexCom, Inc.

$26B

Q3 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$650M+29.8% YoY

Gross Profit

$447M68.7% margin

Operating Income

$118M18.2% margin

Net Income

$71M10.9% margin

EPS (Diluted)

$0.21

QoQ Revenue Growth

+9.3%

Cash Flow

Operating Cash Flow

$247M

Free Cash Flow

$139M

Stock-Based Comp.

$28M

Balance Sheet

Total Assets

$4.8B

Total Liabilities

$2.6B

Stockholders' Equity

$2.1B

Cash & Equivalents

$1.4B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$650M	$501M	+29.8%
Gross Profit	$447M	$340M	+31.3%
Operating Income	$118M	$94M	+25.7%
Net Income	$71M	$72M	-1.8%

Geographic Segments

UNITED STATES

$490M75%

Non-US

$161M25%